UBS Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$355K Buy
215,530
+44,014
+26% +$72.4K ﹤0.01% 5101
2025
Q1
$312K Sell
171,516
-17,253
-9% -$31.4K ﹤0.01% 4998
2024
Q4
$700K Buy
188,769
+141,622
+300% +$525K ﹤0.01% 4486
2024
Q3
$151K Buy
47,147
+7,256
+18% +$23.2K ﹤0.01% 4888
2024
Q2
$328K Sell
39,891
-38,830
-49% -$319K ﹤0.01% 4222
2024
Q1
$1.14M Buy
78,721
+86
+0.1% +$1.25K ﹤0.01% 3456
2023
Q4
$724K Buy
78,635
+30,355
+63% +$280K ﹤0.01% 3684
2023
Q3
$797K Buy
48,280
+7,220
+18% +$119K ﹤0.01% 3267
2023
Q2
$259K Buy
41,060
+13,845
+51% +$87.5K ﹤0.01% 4284
2023
Q1
$92.4K Sell
27,215
-147,607
-84% -$501K ﹤0.01% 4898
2022
Q4
$1.01M Sell
174,822
-167,039
-49% -$965K ﹤0.01% 3130
2022
Q3
$3.21M Buy
341,861
+340,968
+38,182% +$3.2M ﹤0.01% 2033
2022
Q2
$20K Sell
893
-838
-48% -$18.8K ﹤0.01% 5825
2022
Q1
$95K Buy
1,731
+140
+9% +$7.68K ﹤0.01% 4960
2021
Q4
$105K Buy
1,591
+1,057
+198% +$69.8K ﹤0.01% 5199
2021
Q3
$45K Sell
534
-761
-59% -$64.1K ﹤0.01% 5310
2021
Q2
$164K Sell
1,295
-917
-41% -$116K ﹤0.01% 4477
2021
Q1
$242K Buy
2,212
+207
+10% +$22.6K ﹤0.01% 4382
2020
Q4
$286K Sell
2,005
-2,178
-52% -$311K ﹤0.01% 4048
2020
Q3
$296K Sell
4,183
-1,843
-31% -$130K ﹤0.01% 3758
2020
Q2
$422K Buy
6,026
+5,772
+2,272% +$404K ﹤0.01% 3521
2020
Q1
$9K Sell
254
-5,584
-96% -$198K ﹤0.01% 6065
2019
Q4
$367K Sell
5,838
-3,080
-35% -$194K ﹤0.01% 4146
2019
Q3
$299K Sell
8,918
-2,303
-21% -$77.2K ﹤0.01% 4073
2019
Q2
$291K Buy
11,221
+5,223
+87% +$135K ﹤0.01% 3878
2019
Q1
$99K Buy
5,998
+2,532
+73% +$41.8K ﹤0.01% 4289
2018
Q4
$38K Sell
3,466
-3,755
-52% -$41.2K ﹤0.01% 5413
2018
Q3
$181K Buy
7,221
+189
+3% +$4.74K ﹤0.01% 4306
2018
Q2
$153K Buy
7,032
+3,341
+91% +$72.7K ﹤0.01% 4277
2018
Q1
$54K Buy
+3,691
New +$54K ﹤0.01% 4809